Skip to main content

Closed

TARA: Protara Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin0.0%

ROIC-38.0%

Financially safe

Stretched

Debt / equity0.02×

Interest coverage0.0×

Current ratio15.69×

Protara Therapeutics, Inc.

TARANASDAQ Global Market·USD·Closed

Protara Therapeutics, Inc.

TARANASDAQ·USD·Closed

$3.92

−2.73%

$3.92

−$0.11 (2.73%)

52W Range

20thpctl

Volume

0.41×avg

Mkt Cap

220.32MUSD

P/E

-2.7TTM

Div Yield

–ann

52W Range

20thpctl

Volume

0.41×avg

Market Cap

220.32MUSD

P/E Ratio

-2.7TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings